Clinical Trial

Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Most newborns experiencing Neonatal Abstinence Syndrome (NAS) require non-pharmacologic care, which entails, most importantly, maternal involvement with her newborn. To facilitate positive maternal-newborn interactions, mothers need to learn effective caregiving NAS strategies while they are pregnant, yet, an enormous gap exists in the early education of mothers on the symptoms and progression of NAS, in part because no interventions exist to prepare future mothers for the challenges of caring for their newborns at risk for NAS. In this project, the investigators propose to adapt an existing mobile NAS tool for high-risk pregnant women and assess its usability, acceptability, and feasibility in a small randomized controlled analog trial.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2021-03-02; most recent amendment 2026-02-03.
Status change: Recruiting → Active, Not Recruiting 2026-02-03
Status change: Not Yet Recruiting → Recruiting 2024-07-22
Trial Details
NCT Number NCT04783558
Lead Sponsor Washington State University
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Neonatal Abstinence Syndrome, Opioid-use Disorder
Enrollment 30 participants
Start Date 2024-07-15
Primary Completion 2026-09-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-05